The study followed nearly 17 million people, the majority of whom were in the 26-75 age range, and found that after climbing ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

A recent Senate hearing has brought renewed attention to the growing concerns over processed foods and their impact on public ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Statements by Robert F. Kennedy Jr. and Elon Musk tap into a dispute over whether lifestyle changes or drugs are a better way ...

Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

Obesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA ...

The most-read obesity articles of 2024 mostly focused on insurance coverage of weight loss medications and costs.

Semaglutide and similar medications could be key players in bending the curve but enduring change ultimately hinges on a ...

For the first time in a decade, adult obesity in the United States dropped last year, a new study has found, and researchers are curious how the rise in popularity of weight loss drugs like ...